Article History
Received: 26 April 2018
Accepted: 5 July 2018
First Online: 27 July 2018
Compliance with ethical standards
:
: Dina Ginzberg: none. Robert Wong: research funding, advisory board, consulting, speaker’s bureau—Gilead; research funding: Abbvie; speaker’s bureau: Salix, Bayer. Robert Gish: Dr. Gish has received Grants/research support from AbbVie, Benitec Biopharma, Gilead Sciences, and Merck & Co. Dr. Gish has performed as consultant and/or advisor to AbbVie, Akshaya Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Genentech, Gilead Sciences, Hoffman-LaRoche, Ltd., Ionis Pharmaceuticals, Janssen, Merck & Co., Nanogen Biopharmaceutical, and Presidio Pharmaceuticals. Dr. Gish has current activity with the scientific or clinical advisory boards of AbbVie, AstraZeneca, Genentech, Gilead Sciences, Janssen, Merck & Co., and Nanogen Biopharmaceutical. Dr. Gish is a member of the Speakers Bureau for AbbVie, Bristol-Myers Squibb, Gilead Sciences, and Merck. Dr. Gish is a minor stock shareholder of Cocrystal Pharma.
: This article does not contain any studies with human or animal subjects.
: Not applicable as this is a review paper.
: Informed consent was not required given that this is a review paper.